China Money Network
Login
Join

Morningside Venture Invests In Series A Round In US Gene Therapy Company

  • January 8, 2019 — 16:50 CST

This Data Is Locked!

This area is available only to Subscribers.

Apic Bio, Inc., an American gene therapy company for treatment of rare genetic diseases, has raised US$40 million, led by Chinese early-stage venture capital group... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: